EGFR and systemic sclerosis: EGFR-binding autoantibodies have previously been reported in SSc patients, as well as in SLE patients and autoimmune mice [49], but those antibodies had neutralizing or inhibitory effects on A431 cells with the inhibition of DNA synthesis.